Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ALVOW

Market Cap: $2.74B

AL

Alvotech

ALVOW
NASDAQ (NASDAQ Global Market)USD
Purchase ALVOW
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin60.45%
EBITDA Margin-0.29%
EBIT Margin-7.07%
Pre-tax Margin-6.54%
Net Profit Margin-36.51%
Earnings Yield-9.51%
Valuation Multiples
Price / Book-9.86
Price / Sales3.64
Price / Earnings-9.05
PEG0.10
Forward PEG0.01
EV / Sales6.30
EV / EBITDA-2174.19
EV / Operating Cash Flow-15.59
EV / Free Cash Flow-10.32
Price / Free Cash Flow-5.96
Price / Operating Cash Flow-9.50
Cash Flow & Capital
Free Cash Flow / Share-$0.84
Operating Cash Flow / Share-$0.56
Free Cash Flow Yield-16.78%
Capex / Revenue20.64%
Capex / Operating Cash Flow-51.10%
Capex / Depreciation2.46
Stock Compensation / Revenue3.27%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio1.65
Quick Ratio0.96
Cash Ratio0.43
Debt / Assets0.91
Debt / Capital1.15
Debt / Equity-7.58
Long-Term Debt / Capital1.18
Debt / Market Cap73.66%
Net Debt / EBITDA-918.62
Solvency Ratio-0.08
Financial Leverage-8.29
Efficiency & Working Capital
Asset Turnover0.31
Fixed Asset Turnover0.95
Inventory Turnover0.86
Receivables Turnover4.26
Payables Turnover1.46
Days Sales Outstanding85.64
Days Inventory Outstanding424.99
Days Payables Outstanding249.8
Operating Cycle510.64
Cash Conversion Cycle260.84
Working Capital Turnover2.40
Returns & Quality
Return on Equity76.83%
Return on Assets-11.31%
Return on Invested Capital3.61%
ROCE3.77%
Return on Tangible Assets-12.54%
Operating Return on Assets3.15%
Income Quality1.11
Tax Burden5.58
Interest Burden0.92
Balance Sheet & Intrinsic Metrics
Enterprise Value$3.1B
Invested Capital$884.03M
Working Capital$213.79M
Tangible Asset Value$-346.42M
Net Current Asset Value$-1.23B
Graham Net-Net-$4.03
Book Value / Share-$0.54
Tangible Book Value / Share-$0.97
Cash / Share$0.4
Financial Health Scores
Piotroski Score0
Altman Z-Score-0.99
Revenue$492.16M
EBIT$45.05M
Market Cap$1.87B
Working Capital$213.79M
Retained Earnings$-2.48B
Total Assets$1.59B
Total Liabilities$1.78B